Loading candles…
Zenith Drugs Ltd, incorporated in 2000, operates in the pharmaceutical industry as a manufacturer and marketer of generic pharmaceutical formulations. The company produces a range of dosage forms including tablets, capsules, and liquid orals. Its operations focus on providing affordable healthcare solutions through generic medicines and it serves both domestic markets in India as well as international markets. Zenith Drugs Ltd functions primarily as a formulation manufacturer without listed subsidiaries or ventures. No information regarding founders, key management, headquarters, or stock exchange listings is provided.
This page is a live market overview for ZENITH DRUGS LIMITED (ZENITHDRUG) on the NSE. As a listed security, ZENITH DRUGS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ZENITHDRUG before placing trades on tick2trade.
As of the latest feed, ZENITHDRUG last traded at ₹42 on NSE, down ₹2 (4.55%) from the previous close of ₹44. Today's session range is ₹40.5 – ₹44.95, against a 52-week band of ₹33.3 – ₹76. Traded volume today stands at 69.60K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for ZENITHDRUG in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ZENITHDRUG is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ZENITH DRUGS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ZENITHDRUG. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ZENITHDRUG option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.